EquityZen Growth Technology Fund LLC - Series 2117
Raised
$1M
Investors
58
Min Invest
$10,011
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2117 is a Delaware LLC filed by EquityZen Advisors on August 5, 2025, raising $1.2M from 58 investors under Rule 506(b) and Section 3(c)(1). The offering has a $10K minimum investment and operates as part of EquityZen's pre-IPO secondary marketplace platform, which manages over 1,800 related entities.
This pre-IPO pooled investment fund uses the standard 506(b)/3(c)(1) exemption pattern common to private secondary market vehicles. The $10K minimum investment represents an accessible entry point relative to typical pre-IPO opportunities, consistent with EquityZen's platform model of democratizing access to late-stage private company shares through SPV structures.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
